eBook: Raw materials and supply chain management in GMP cell and gene therapies
Download peer-reviewed content and expert insights in our latest eBook.
The journey from bench to bedside in cell and gene therapy is uniquely complex, requiring rigorously controlled manufacturing environments where every raw material, including culture media, must meet stringent quality standards while remaining consistently available.
This eBook examines raw material management and supply chain optimization in GMP cell and gene therapy manufacturing through exclusive peer-reviewed research, expert interviews, technical notes and strategic perspectives.
Expert perspectives on current challenges
Our featured interview explores the practical realities of managing GMP media and navigating raw material qualification and vendor management, providing actionable strategies for overcoming common manufacturing bottlenecks.
Technical deep dives
From understanding critical components of cell and gene therapy media to exploring mesenchymal stem cell cultivation in single-use stirred tank bioreactors, this eBook provides the technical knowledge needed to optimize manufacturing processes while maintaining GMP compliance.
Exclusive research access
This collection features four peer-reviewed research articles from the Taylor & Francis portfolio, normally available only through journal subscriptions, covering both cell and gene therapy applications, and exploring the evolving regulatory landscape for cell-based therapies.
Practical solutions
Whether you’re exploring pilot-scale manufacturing or seeking to understand how raw material variability affects therapeutic potential, this eBook offers practical frameworks and proven approaches for immediate implementation.
eBook contents:
- INTERVIEW Addressing supply chain challenges: Expert insights on GMP media, xeno-free solutions and raw material management
- OPINION Cell and gene therapy media and reagents: the breakdown
- APPLICATION NOTE Mesenchymal stem cell cultivation in single-use stirred tank bioreactors
- FLYER Pilot Evaluation Batch program
- REVIEW Development and clinical translation considerations for the next wave of gene modified hematopoietic stem and progenitor cell therapies
- REVIEW Clinical applications of induced pluripotent stem cell-mediated therapies in cancer: progress, challenges, and future directions
- REVIEW Stress kinases negatively regulate the multipotency of mesenchymal stem/stromal cells in vitro: implications in regenerative medicine
- REVIEW Regulatory challenges and opportunities in cell-based therapies: overcoming barriers to advancement and patient care
